Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Cetuximab can cause unusual hair growth and hair loss.

There is a significant need for better-validated quality of life tools in dermatology.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Scientists developed a new method to deliver alopecia treatment directly to hair follicles, which could be a promising treatment for hair loss and other hair diseases.

Nivolumab can cause hair loss as a rare side effect.

Using microneedling with platelet-rich plasma is more effective and just as safe as microneedling alone for treating acne scars.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The hair follicle pathway significantly affects how easily water-loving chemicals pass through the skin.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Marine algae compounds may improve skin health and promote hair growth.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Total skin electron therapy is an effective treatment for mycosis fungoides, balancing effectiveness and side effects.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

High-dose methotrexate can cause severe skin and nail issues.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Drinking kava tea can cause a skin reaction with red, swollen bumps, which may improve with steroids.